Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Papillomavirus Infections × Injections × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 35 Breast Neoplasms 17 Advanced Solid Tumors 16 Myelodysplastic Syndromes 14 Advanced Solid Tumor 11 Recurrence 9 Carcinoma, Non-Small-Cell Lung 9 Leukemia, Myelomonocytic, Chronic 8 Neoplasms 7 Myeloproliferative Disorders 6 Multiple Myeloma 6 Lymphoma, Large B-Cell, Diffuse 6 Triple Negative Breast Neoplasms 5 Solid Tumor 5 Ovarian Neoplasms 5 Advanced Solid Tumour 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Pancreatic Neoplasms 4 Lymphoma, B-Cell 4 Lung Neoplasms 4 Carcinoma, Hepatocellular 4 Advanced Malignant Solid Tumor 4 Stomach Neoplasms 3 Small Cell Lung Carcinoma 3 Sarcoma 3 Prostatic Neoplasms 3 Primary Myelofibrosis 3 Neuroendocrine Tumors 3 Neoplasm Metastasis 3 Myelodysplastic-Myeloproliferative Diseases 3

Interventions

Specimen Handling 7 Human Papillomavirus Recombinant Vaccine nonavalent 6 Colposcopy 5 Radiotherapy, Intensity-Modulated 4 Human Papillomavirus DNA Tests 4 Early Intervention, Educational 4 Cisplatin 4 artesunic acid 3 artemisinin 3 Papillomavirus Vaccines 3 Methods 3 human papillomavirus vaccine, L1 type 16, 18 2 artenimol 2 Surveys and Questionnaires 2 Patient Navigation 2 Mass Screening 2 Educational Status 2 Docetaxel 2 Carboplatin 2 Blood Specimen Collection 2 Biopsy 2 toripalimab 1 fludarabine phosphate 1 fludarabine 1 epigallocatechin gallate 1 aldesleukin 1 adacel 1 Watchful Waiting 1 Vitamin B 12 1 Triage 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04199689 2025-03-25

V503-049

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡